Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice

Life Sciences

Volumn 95, Issue 1, 2014, Pages 29-39

  Lee, Changhyun ^a   Chun, Jaeyoung ^a   Hwang, Sung Wook ^a   Kang, Seung Joo ^a   Im, Jong Pil ^a   Kim, Joo Sung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Angiotensin converting enzyme inhibitors; Enalapril; Inflammatory bowel disease; NF kappa B; Renin angiotensin system

Indexed keywords

DEXTRAN SULFATE; ENALAPRIL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PIROXICAM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL STIMULATION; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DNA BINDING; DOWN REGULATION; EXPERIMENTAL COLITIS; GEL MOBILITY SHIFT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WEIGHT REDUCTION; WESTERN BLOTTING; WILD TYPE;

MURINAE; MUS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ENALAPRIL; INFLAMMATORY BOWEL DISEASE; NF-KAPPA B; RENIN-ANGIOTENSIN SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL LINE; COLITIS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENALAPRIL; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-10; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PHOSPHORYLATION; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84892364541     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.11.005     Document Type: Article

References (52)

1. C. Abraham, and J.H. Cho Inflammatory bowel disease N Engl J Med 361 2009 2066 2078
2. - splenic T cell numbers Cell Immunol 260 2010 92 97
3. A. Andou, T. Hisamatsu, S. Okamoto, H. Chinen, N. Kamada, and T. Kobayashi et al. Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages Gastroenterology 136 2009 564 574 [e2]
4. I. Atreya, R. Atreya, and M.F. Neurath NF-kappaB in inflammatory bowel disease J Intern Med 263 2008 591 596
5. D.J. Berg, J. Zhang, J.V. Weinstock, H.F. Ismail, K.A. Earle, and H. Alila et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice Gastroenterology 123 2002 1527 1542
6. J.H. Cheon, J.S. Kim, J.M. Kim, N. Kim, H.C. Jung, and I.S. Song Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis Inflamm Bowel Dis 12 2006 1152 1161
7. S.J. Cho, J.S. Kim, J.M. Kim, J.Y. Lee, H.C. Jung, and I.S. Song Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice Int J Cancer 123 2008 951 957
8. L.A. Dieleman, B.U. Ridwan, G.S. Tennyson, K.W. Beagley, R.P. Bucy, and C.O. Elson Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice Gastroenterology 107 1994 1643 1652
9. L. Fandriks The renin-angiotensin system and the gastrointestinal mucosa Acta Physiol (Oxf) 201 2011 157 167
10. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788
11. R.A. Gonzalez-Villalobos, X.Z. Shen, E.A. Bernstein, T. Janjulia, B. Taylor, and J.F. Giani et al. Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme J Mol Med (Berl) 91 2013 1143 1154 10.1007/s00109-013-1051-z
12. K. Hirasawa, Y. Sato, Y. Hosoda, T. Yamamoto, and H. Hanai Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa J Histochem Cytochem 50 2002 275 282
13. Y. Inokuchi, T. Morohashi, I. Kawana, Y. Nagashima, M. Kihara, and S. Umemura Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice Gut 54 2005 349 356
14. R. Jaszewski, V. Tolia, M.N. Ehrinpreis, J.H. Bodzin, R.R. Peleman, and R. Korlipara et al. Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis Gastroenterology 98 1990 1543 1548
15. C. Jobin, S. Haskill, L. Mayer, A. Panja, and R.B. Sartor Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells J Immunol 158 1997 226 234
16. S.J. Kang, J.M. Kim, S.J. Koh, S.H. Kim, J.P. Im, and H.C. Jung et al. The guggulsterone derivative GG-52 inhibits NF-kappaB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout mice Life Sci 92 2013 1064 1071
17. D.A. Kasal, and E.L. Schiffrin Angiotensin II, aldosterone, and anti-inflammatory lymphocytes: interplay and therapeutic opportunities Int J Hypertens 2012 2012 829786
18. S. Katz, and D.S. Pardi Inflammatory bowel disease of the elderly: frequently asked questions (FAQs) Am J Gastroenterol 106 2011 1889 1897
19. J.M. Kim, H.W. Kang, M.Y. Cha, D. Yoo, N. Kim, and I.K. Kim et al. Novel guggulsterone derivative GG-52 inhibits NF-kappaB signaling in intestinal epithelial cells and attenuates acute murine colitis Lab Invest 90 2010 1004 1015
20. J.S. Kim, and C. Jobin The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells Immunology 115 2005 375 387
21. S.J. Koh, J.M. Kim, I.K. Kim, N. Kim, H.C. Jung, and I.S. Song et al. Fluoxetine inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice Am J Physiol Gastrointest Liver Physiol 301 2011 G9 G19
22. R. Kranzhofer, M. Browatzki, J. Schmidt, and W. Kubler Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes Biochem Biophys Res Commun 257 1999 826 828
23. R. Krysiak, and B. Okopien Pleiotropic effects of angiotensin-converting enzyme inhibitors in normotensive patients with coronary artery disease Pharmacol Rep 60 2008 514 523
24. R. Krysiak, and B. Okopien Lymphocyte-suppressing action of angiotensin-converting enzyme inhibitors in coronary artery disease patients with normal blood pressure Pharmacol Rep 63 2011 1151 1161
25. R. Krysiak, M. Sierant, B. Marek, R. Bienek, and B. Okopien The effect of angiotensin-converting enzyme inhibitors on plasma adipokine levels in normotensive patients with coronary artery disease Endokrynol Pol 61 2010 280 287
26. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263 274
27. J.Y. Lee, J.S. Kim, J.M. Kim, N. Kim, H.C. Jung, and I.S. Song Simvastatin inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates acute murine colitis Int Immunopharmacol 7 2007 241 248
28. C. Letizia, A. Picarelli, A. De Ciocchis, F. Di Giovambattista, M. Greco, and S. Cerci et al. Angiotensin-converting enzyme activity in stools of healthy subjects and patients with celiac disease Dig Dis Sci 41 1996 2268 2271
29. F.C. Luft Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases Curr Opin Nephrol Hypertens 11 2002 59 66
30. J. Lv, V. Perkovic, C.V. Foote, M.E. Craig, J.C. Craig, and G.F. Strippoli Antihypertensive agents for preventing diabetic kidney disease Cochrane Database Syst Rev 12 2012 [CD004136]
31. T.Y. Ma, G.K. Iwamoto, N.T. Hoa, V. Akotia, A. Pedram, and M.A. Boivin et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation Am J Physiol Gastrointest Liver Physiol 286 2004 G367 G376
32. G. Mancia, R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti, and M. Bohm et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 34 2013 2159 2219
33. S. Melgar, L. Karlsson, E. Rehnstrom, A. Karlsson, H. Utkovic, and L. Jansson et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease Int Immunopharmacol 8 2008 836 844
34. A. Mizoguchi, and E. Mizoguchi Animal models of IBD: linkage to human disease Curr Opin Pharmacol 10 2010 578 587
35. N.A. Molodecky, I.S. Soon, D.M. Rabi, W.A. Ghali, M. Ferris, and G. Chernoff et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 2012 46 54 [e42]
36. S.Y. Nam, J.S. Kim, J.M. Kim, J.Y. Lee, N. Kim, and H.C. Jung et al. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis Exp Biol Med (Maywood) 233 2008 180 191
37. M.F. Neurath, S. Pettersson, KH Meyer zum Buschenfelde, and W Strober Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice Nat Med 2 1996 998 1004
38. T. Nishida, S. Tsutsui, M. Kato, T. Inoue, S. Yamamoto, and Y. Hayashi et al. Treatment strategy for gastric non-invasive intraepithelial neoplasia diagnosed by endoscopic biopsy World J Gastrointest Pathophysiol 2 2011 93 99
39. A. Oeckinghaus, M.S. Hayden, and S. Ghosh Crosstalk in NF-kappaB signaling pathways Nat Immunol 12 2011 695 708
40. M. Ravid, H. Savin, I. Jutrin, T. Bental, B. Katz, and M. Lishner Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients Ann Intern Med 118 1993 577 581
41. A. Ray, and B.N. Dittel Isolation of mouse peritoneal cavity cells J Vis Exp 2010 10.3791/1488 (in press)
42. G. Rogler, K. Brand, D. Vogl, S. Page, R. Hofmeister, and T. Andus et al. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa Gastroenterology 115 1998 357 369
43. 2 in vascular smooth muscle cells: molecular mechanisms Circ Res 86 2000 1266 1272
44. O.I. Santiago, E. Rivera, L. Ferder, and C.B. Appleyard An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis Regul Pept 146 2008 250 259
45. B. Schieffer, C. Bunte, J. Witte, K. Hoeper, R.H. Boger, and E. Schwedhelm et al. Comparative effects of AT1-antagonism and angiotensin- converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease J Am Coll Cardiol 44 2004 362 368
46. A.U. Spencer, H. Yang, E.Q. Haxhija, B.E. Wildhaber, J.K. Greenson, and D.H. Teitelbaum Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition Dig Dis Sci 52 2007 1060 1070
47. M. Takahashi, E. Suzuki, R. Takeda, S. Oba, H. Nishimatsu, and K. Kimura et al. Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species Am J Physiol Heart Circ Physiol 294 2008 H2879 H2888
48. M.E. van der Valk, M.-J.J. Mangen, M. Leenders, G. Dijkstra, A.A. van Bodegraven, and H.H. Fidder et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study Gut 2012 10.1136/gutjnl-2012-303376 (Electronic publication ahead of print)
49. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey, and M.H. Drazner et al. 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 2013 e240 e327
50. A.J. Yarur, A.R. Deshpande, D.M. Pechman, L. Tamariz, M.T. Abreu, and D.A. Sussman Inflammatory bowel disease is associated with an increased incidence of cardiovascular events Am J Gastroenterol 106 2011 741 747
51. T. Yoshino, H. Nakase, Y. Honzawa, K. Matsumura, S. Yamamoto, and Y. Takeda et al. Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis Inflamm Bowel Dis 16 2010 2022 2033
52. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153